Syp Looz (Lactulose) vs Dulcolax (Bisacodyl)

What They Are

Which is Better - and When?

• You need long-term / chronic constipation management - it is gentler and proven safe for extended use
• Elderly patients - lower risk of electrolyte disturbance and cramping
• Children - well-established safety profile
• Pregnancy - considered safer (though PEG is now preferred over lactulose in pregnancy per recent guidelines)
• Hepatic encephalopathy - lactulose has a specific added benefit here (reduces ammonia absorption); bisacodyl has no role
• Patient has comorbidities like cardiac or renal disease where electrolyte shifts are risky
• A 2023 review published in Bagcilar Medical Bulletin concluded lactulose is preferred for long-term use, elderly patients, and those with comorbidities

• You need rapid, short-term relief - it acts within 6-10 hours (oral) or 30 minutes (suppository)
• Pre-procedure bowel prep (e.g., before colonoscopy or surgery)
• Acute constipation that needs urgent treatment
• Lactulose has failed or is not tolerated
• Note: bisacodyl is generally recommended for short-term use only (up to 4 weeks)

Side Effects

Bottom Line

• For ongoing/chronic constipation - Syp Looz (lactulose) is generally the better, safer choice
• For quick/immediate relief - Dulcolax (bisacodyl) works faster
• For hepatic encephalopathy - Lactulose only
• They can be used together in severe cases (e.g., in patients on clozapine or with opioid-induced constipation)

Note: This is general medical information. The right choice depends on the individual patient's age, diagnosis, comorbidities, and clinical urgency. Always consult a doctor or pharmacist for specific cases.

Wall Thickening of the Proximal Stomach - Causes

MALIGNANT CAUSES (Most Important to Exclude)

1. Gastric Adenocarcinoma - Linitis Plastica

• The most feared cause. Diffuse submucosal infiltration leads to a rigid, non-distensible "leather bottle" stomach
• Presents as diffuse thickening of folds throughout the body/fundus, often edematous and erythematous
• Mucosal biopsies are frequently negative - deeper tissue sampling (large particle biopsy, EUS-FNA, or laparoscopic full-thickness biopsy) is needed
• On EUS: loss of wall layer pattern and thickening in the muscularis propria (layer 4) is most concerning for malignancy
• On CT: focal/eccentric thickening ≥1 cm with differential enhancement (hyperenhancement due to neovascularity) is specific for malignancy

2. Gastric Lymphoma

• Various subtypes of non-Hodgkin's lymphoma (e.g., MALT lymphoma, mantle cell lymphoma, diffuse large B-cell lymphoma) can infiltrate the gastric wall
• Causes significantly greater wall thickening than adenocarcinoma on imaging
• Key distinguishing feature: distensibility of the stomach is often maintained (unlike linitis plastica)
• Mucosa is edematous and erythematous
• Treatment differs markedly from adenocarcinoma, so accurate diagnosis is essential

3. Metastatic Disease

• Lobular breast cancer is the classic metastasis to the stomach that mimics linitis plastica
• Also: lung cancer, melanoma
• May present as diffuse thickening - difficult to diagnose on surface biopsies alone

4. GIST (Gastrointestinal Stromal Tumor)

• Arises from the muscularis propria (layer 4 on EUS)
• Thickening is typically a submucosal mass rather than diffuse fold thickening
• CT with IV contrast is imaging of choice; shows a enhancing exophytic or intramural mass

BENIGN CAUSES

5. Menetrier's Disease

• Rare condition causing giant/diffuse thickened folds, most pronounced in the fundus and body
• Classic clinical triad: weight loss + peripheral edema + diarrhea due to protein-losing enteropathy
• EUS shows thickening in layers 2 and 3 (mucosa/submucosa) - different from malignancy
• Histology: foveolar hyperplasia, cystic dilation, glandular atrophy
• Associated with H. pylori infection and CMV (especially in children)
• Treatment: H. pylori eradication, anti-EGFR monoclonal antibodies (cetuximab); gastrectomy in refractory cases

6. Gastritis (Inflammatory / Infectious)

• H. pylori gastritis: thickened, nodular folds, predominantly antrum but can extend proximally
• CMV gastritis: seen in immunocompromised patients; can produce marked fundal thickening
• Eosinophilic gastritis: any layer can be involved; associated with eosinophilia and food allergies
• Granulomatous gastritis (Crohn's, sarcoidosis, TB): rare; transmural involvement

7. Gastric Varices

• Portal hypertension leads to submucosal varices in the fundus (fundal varices are at highest risk of bleeding)
• Appear as tortuous, bluish submucosal bulges - confirmed on Doppler EUS
• CT/MRI shows enhancing tubular structures in the gastric wall

8. Zollinger-Ellison Syndrome (Gastrinoma)

• Massive hypersecretion of gastric acid due to a gastrin-secreting tumor
• Causes prominent, hypertrophied rugal folds particularly in the fundus and body
• Associated with recurrent peptic ulcers and diarrhea

9. Hypertrophic Gastropathy / Hyperplastic Gastropathy

• Benign overgrowth of mucosa; can mimic Menetrier's on imaging
• Less pronounced protein loss compared to Menetrier's

10. Submucosal Lesions (Lipoma, Cyst, Duplication)

• Focal wall thickening from a submucosal mass
• EUS characterizes the layer of origin and internal echo pattern

EUS-Based Diagnostic Approach

Red Flag Features Suggesting Malignancy

• Loss of wall layer architecture on EUS
• Thickening ≥1 cm, eccentric, enhancing on CT
• Poor distensibility on endoscopy
• Accompanying ascites, lymphadenopathy, or distant metastases
• Symptoms: early satiety, weight loss, anemia